Since a landmark 2009 study, researchers have known that a common gut bacterium, Bacteroides fragilis, drives colon tumor formation, potentially leading to colorectal cancer, by secreting a toxin that ...
Many cancer patients turn to biotin supplements hoping to restore hair lost during treatment, but experts warn the popular ...
Pembrolizumab combined with gemcitabine-based chemoradiation is feasible and effective in patients with muscle-invasive bladder cancer (MIBC).
Three separate announcements revealed advancements in oncology: FDA clearance for ArteraAI Breast, a GSK-Halozyme agreement ...
Researchers at the Icahn School of Medicine at Mount Sinai and the Mount Sinai Tisch Cancer Center have identified a ...
A simple blood test can reveal the geographic relationships among healthy cells surrounding a cancerous tumor, researchers at ...
This Research Topic is one volume within the series "The Future of Checkpoint Immunotherapy: New Roads Ahead". Please see the ...
( NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced it will present new treatment comparison results evaluating ANKTIVA ® (nogapendekin alfa inbakicept-pmln) plus Bacillus ...
Every participant in a new bowel cancer immunotherapy trial remained cancer-free nearly three years after receiving ...
LUCAS, a first of its kind, state-of-the-art mobile lung cancer screening unit, will visit Hancock, Brooke, and Tucker ...
Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal immunotherapies to improve outcomes for patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results